Schizophrenia

BioXcel Therapeutics BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2…

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that the relatively high…

For Henry Cockburn, the onset of schizophrenia felt like pure common sense.It was February 2002, and the 20-year-old…

One in every eight people — 970 million globally — live with mental illness, according to the World…

Mental health disorders could be a driving factor in heart-related deaths. (© pixelheadphoto – stock.adobe.com) Study Shows Anxiety,…

BioXcel Therapeutics BXCL501 achieved SERENITY At-Home’s primary endpoint of being well tolerated in the at-home treatment of agitation…

Every 34 seconds, someone in the United States dies from heart disease. As nearly half of the country suffers from…

BioXcel Therapeutics Data from more than 2,600 agitation episodes collected Topline data readout is on track for August …

In a new study led by the University of Pennsylvania School of Veterinary Medicine (Penn Vet) and Children’s…

Lally, J. & MacCabe, J. H. Antipsychotic medication in schizophrenia: a review. Br. Med. Bull. 114, 169–179 (2015).…

Summary: The largest exome-sequencing study of schizophrenia to date has uncovered eight new genes tied to the disorder.…

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia